Franklin Resources
VYGR icon

Franklin Resources’s Voyager Therapeutics VYGR Stock Holding History

Franklin Resources’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-61,047
Closed -$346K – 3072
2024
Q4 		$346K Sell
61,047
-54,070
-47% -$349K ﹤0.01% 2451
2024
Q3 		$847K Sell
115,117
-1,415
-1% -$10.3K ﹤0.01% 2059
2024
Q2 		$922K Buy
116,532
+8,611
+8% +$72.2K ﹤0.01% 1956
2024
Q1 		$1M Buy
107,921
+93,799
+664% +$792K ﹤0.01% 1950
2023
Q4 		$119K Sell
14,122
-14,821
-51% -$108K ﹤0.01% 2449
2023
Q3 		$224K Sell
28,943
-1,638
-5% -$15K ﹤0.01% 2273
2023
Q2 		$350K Buy
30,581
+12,772
+72% +$132K ﹤0.01% 2137
2023
Q1 		$137K Hold
17,809
– – ﹤0.01% 2070
2022
Q4 		$109K Hold
17,809
– – ﹤0.01% 2109
2022
Q3 		$105K Buy
17,809
+188
+1% +$1.2K ﹤0.01% 2098
2022
Q2 		$104K Buy
+17,621
New +$119K ﹤0.01% 2145

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources's VYGR Position: Q1 2025 in Review

Franklin Resources sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 61,047 shares — an estimated $346K sold.

Franklin Resources first reported a position in VYGR in Q2 2022 and held it in 11 quarters. The position peaked at $1M in Q1 2024. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Franklin Resources reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Franklin Resources sold 61,047 Voyager Therapeutics shares in Q1 2025, an estimated $346K.
  • Franklin Resources first reported a position in Voyager Therapeutics in Q2 2022 and held it in 11 quarters.
  • Franklin Resources's Voyager Therapeutics position peaked at $1M in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.